Ethan Paul

Bioprinting Market annual growth rate (CAGR) of 35.4% for the period 2019 to 2024

2020-01-28T09:45:38.108Z

The global bioprinting market should reach $1.4 billion by 2024 from $306.2 million in 2019 at a compound annual growth rate (CAGR) of 35.4% for the period 2019 to 2024.

Report Scope:

This new BCC Research report on the topic “Current Bioprinting Prospects and Future Innovations” offers a detailed perspective on bioprinting technology, its current market and future prospects. The report provides a comprehensive analysis of the trending applications of bioprinting in the market in the global context, including market forecasts and sales through 2024. The report is focused on the analysis of the bioprinting market by various product types, regions and applications.

Request Report For Sample: https://www.trendsmarketresearch.com/report/sample/11647

The products that matter the most, i.e., instruments (bioprinters), reagents (bioinks), 3D cell culture products, and software and services, are discussed and analyzed. Each of these segments are sub-divided into different types (as detailed later). The emphasis is on the printing instruments, reagents, tissue products, skin substitutes, etc. The report also highlights the popular and emerging applications of bioprinting in the clinical and research domains. The end user markets, i.e., research and development, cosmetics, drug discovery, clinical and others, are analyzed in this report. Other end user markets include chemical, agrochemical, educational, hobbyist and veterinary applications. This study includes a survey of the bioprinting market in all geographic regions, including North America, Europe, and Emerging markets. The Emerging markets include regions like India, China, Korea, Taiwan, Africa, Australia, New Zealand, Canada, Latin America, among others.

The report elaborates on the critical issues and challenges facing the bioprinting industry as well as emerging trends in bioprinting technologies. It additionally features the new developments and new product launches in the global market.

The new BCC report provides relevant patent analysis and comprehensive profiles of market players in the industry. The industry structure chapter focuses on changing market trends, important manufacturers/suppliers, their market shares and product offerings. The chapter also covers mergers and acquisitions and any other collaborations or partnerships that happened during the evaluation period of this report that are expected to shape the industry.

Factors such as the strengths, weaknesses, threats and opportunities that are expected to play a role in the evolution of the bioprinting market are also evaluated. Any regulatory changes or new initiatives are highlighted explicitly.

Excluded from this report is medical 3D printing, which focuses on nonliving materials used in medical devices. Examples of medical devices that are not covered include treatment models, surgical tools and guides, prosthetics, dental restorations and crowns, and surgical implants.

Report Includes:

- 85 data tables and 27 additional tables
- Comprehensive analysis of the bioprinting technologies and their trending applications in the market at a global scale
- Analyses of the global market trends with data from 2017 to 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Segmentation of the global market by technologies and products, notably instruments (bioprinters), reagents (bioinks), 3D cell culture products, and software and services
- Focus on the popular and emerging applications of bioprinting in the clinical and research domains
- Regional dynamics of bioprinting technologies covering North America, Europe and Other emerging markets including India, China, Korea, Taiwan, Africa, Australia, New Zealand, Canada, Latin America etc.
- Discussion of new developments and new product launches in the global bioprinting market
- A relevant patent analysis
- Company profiles of market players in the industry, including 3Dynamic Systems Ltd., Aspect Biosystems, GeSiM, n3D Biosciences Inc., Organovo Holdings Inc., Prellis Biologics Inc. and regenHU Ltd.

Get Request for Discount: https://www.trendsmarketresearch.com/report/discount/11647

Summary

Bioprinting is a form of additive manufacturing technology, that can be used to fabricate biomimicking 3D tissue constructs and organs. The reliability and accuracy offered by these 3D tissue structures and organ constructs have made them highly attractive for a number of applications. The use of stem cells in bioprinting has significant prospects in the area of personalized medicine, to develop customized tissues/organs for repair or for the fabrication of personalized 3D tissue models for drug toxicity testing.

There is a huge unmet demand for organs. Bioprinting of 3D organs has the potential to reduce the endless wait lists of organ donations and revolutionize the medical industry. Though a number of studies are going on catering to the development of fully, functional organs by bioprinting, a number of challenges remain. These pertain to the fabrication of complex tissues with multiple cell types, the issue of resolution, and the incorporation of vascularization, among other factors.

Despite these challenges, 3D bioprinting has undergone extensive progress and is used in many other applications. The 3D tissues being biofabricated can be used for tissue engineering and regenerative medicine. From the treatment of wounds (3D skin tissues), to craniomaxillofacial repair and orthopedic reconstructive surgeries (bone grafts), to the vascular grafts used to treat the growing number of heart disease patients—these are just some of the potential clinical applications of bioprinting. In addition, in situ bioprinters that have the ability to treat the wounds/injuries by directly printing cells at a wound site are also gaining immense popularity.

One of the main drivers of the bioprinting market are the applications of 3D tissue constructs and biofabricated organ-on-chips for in vitro drug testing. The pharmaceutical industry is constrained by a high rate of drug failures at the clinical stage. Bioprinted 3D models reproduce natural tissues very closely and, therefore, are ideal materials for in vitro drug testing and other preclinical testing studies. The potential of 3D tissues to alleviate the burden on animal testing is another reason for their increased popularity. Poietis recently launched the biofabricated skin tissue, Poieskin, which can be used for cosmetic testing applications. Moreover, a multitude research organizations and universities are
developing 3D tissue models for disease modeling, drug research and cancer studies, among others.

The bioprinting market is propelled by innovations in bioprinting technologies and products encompassing bioprinters, bioinks, software, and 3D tissue products. The number of U.S. patents issued in 2018 (through November 4, 2018) in the field of bioprinting increased to 38, from a total of 27 in 2017. The highest number of patents were issued in the category of 3D cell culture products followed by the bioinks segment. Strategic collaborations and partnerships among research institutes and bioprinting companies along with interested partners from the pharmaceuticals and cosmetics sectors are supporting the growth of bioprinting market in a big way. Other factors driving the growth of the bioprinting market include increased government grants, the rising interest of private venture capitalists supporting several bioprinting start-ups, and the increasing healthcare burden.

Make an enquiry before Buying: https://www.trendsmarketresearch.com/checkout/11647/Single

Biodegradable Stents: Global Markets 2023

2020-01-28T09:45:30.888Z

The global market for biodegradable stents should grow from $106.7 million in 2018 to $378.0 million by 2023 with a compound annual growth rate (CAGR) of 28.8% for the period of 2018-2023.

Report Scope:

This report reviews both global and regional markets of the biodegradable stents market according to available types and application areas. The report analyzes the current market status and trends, and provides growth forecasts for the five-year period 2018 to 2023. The analysis also discusses R&D issues, including global regulatory scenarios and other commercialization hurdles. Additionally, this comprehensive report examines technology developers/manufacturers of biodegradable stents, their product types and geographical product presence (wherever data is available).

The biodegradable stents market is divided into the following types -
- Polymer-based.
- Metal-based.

Request Report For Sample: https://www.trendsmarketresearch.com/report/sample/11646

The report differentiates BDS from conventional metallic DES that have a matrix coating of bioresorbable polymer and antiproliferative drug. These devices, which have typical metallic nondegradable stent backbones, are known as bioresorbable polymer DES, bioabsorbable polymer DES or biodegradable polymer DES. Therefore, this report concentrates only on the BDS market for fully bioabsorbable or biodegradable stents.

The only applications of the biodegradable stent market that have been analyzed in this report includes -
- BDS for vascular disease.
- Coronary BDS.
- Non-coronary vascular BDS.
- BDS for non-vascular disease.
- Ureteral.
- Gastrointestinal.
- Biliary.
- Pancreatic.
- Others.

The report also offers a detailed patent analysis with information on the strategic initiatives of market players within the past five years.

The report specifically excludes stents that are not fully biodegradable and also stents that have bioabsorbable coatings which are not fully bioabsorbable. The report also excludes biomaterial technology/product and equipment providers.

Estimated values used are based on manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Get Request for Discount: https://www.trendsmarketresearch.com/report/discount/11646

Summary

Biodegradable stents/scaffolds (BDS) are an appealing treatment option in both vascular and nonvascular intervention. Although many stent manufacturers have been conducting R&D into novel BDS technology, adoption rate of the technology in clinical care remains low due to complex medical policies and regulations. Most advanced healthcare technologies like biodegradable stents/scaffolds (BDS) require long-term clinical evidence of therapeutic effects at an early stage of commercialization. Key factors driving growth prospects for BDS include a surge in disease incidences due to affluence and lifestyle changes, resulting increase in demand for better disease diagnosis and treatment, and
infrastructure growth driven partially by a fast-growing cluster of corporate hospitals.

The global market for biodegradable stents is still developing with only a handful of products having reached the market. Many are still in pipeline, development, or clinical trial stage. However, the stringent regulatory scenarios across the world coupled with BDS’s high price tag are hindering market growth. Abbott Vascular’s Absorb BVS is the most widely used and researched BDS-eluting everolimus drug. Presently, the product is off the commercial market due to low commercial sales. In order to meet the safety requirement and other unmet needs of the market, researchers and corporate players are making iterative approaches in developing newer generation BDS products by applying the lessons
learned from the older generation.

The major limitation of current generation of BDS is that they lack certain technical characteristics of the current generation DES. Appropriate patient and lesion selection, application of an optimal implantation technique, intravascular imaging guidance, specific DAPT regimen, and overcoming/improvement of the device limitations are key factors of the technology’s potential during the next five years.

Because thicker struts have procedural limitations and reduced vascular healing, miniaturization of strut thickness while maintaining the radial strength is the key requisite for improving current outcomes of BDS technology. Manufacturers are involved in adopting several strategies to improve radial strength and consequently decrease strut thickness of the polymeric scaffold. These include polymer blending, annealing (heat treatment), polymer orientation and extraction of higher molecular weight components. PLLA is the most widely used and researched biomaterial for use in BDS devices as core stent materials. Metallic stent Mg based alloys are finding increased recognition, however. Research is being conducted on many other biomaterials for their suitability as an alternative for metallic DES.

The ripple effects of reduced prices have slashed BDS global sales in 2017 and 2018. The global BDS market fell to REDACTED in 2017 from REDACTED in 2016. In addition, the market withdrawal of the only FDA-approved BDS product, “Absorb GT1” from Abbott Laboratories, in early 2017 induced the global BDS market to fall more than REDACTED that same year. However, anticipated new product launches and increased product penetration in new geographical locations should push the market into recovery in 2018.

Both vascular and non-vascular stenting procedures are expected to grow, but the declining prices of stents is inhibiting overall market growth. Although the ASP of stents has dropped in the past decade, a debate surrounds keeping advanced medical technologies like BDS within the premium product bracket.

Make an enquiry before Buying: https://www.trendsmarketresearch.com/checkout/11646/Single

Advanced Structural Insulation: Global Markets To 2023

2020-01-28T09:45:25.599Z

The global market for structural insulation should grow from $3.0 billion in 2018 to reach $4.5 billion by 2023 at a compound annual growth rate (CAGR) of 8.3% for the period of 2018-2023.

Report Scope:

This study reviews key structural insulation technology categories, along with relevant market and production information, technological descriptions and issues, applications, and market factors and potential, and gives an overview of relevant incentives and regulations in major worldwide markets. This study will be of interest to current and potential manufacturers and suppliers of residential and commercial structural insulation manufacturers, and entrepreneurs and entrepreneurial companies interested in entering or expanding into the structural insulation sector.

Request Report For Sample: https://www.trendsmarketresearch.com/report/sample/11645

The market analysis provided in this report is based on a variety of data sources. These include the most recent government, industry, and corporate data on structural insulation sales, production, imports, and exports; manufacturing rates and detailed commercial building trends used to help gauge historic and anticipated future market growth; data generated by recent and ongoing research and development efforts aimed at identifying new and developing niches for certain classes of structural insulation, and potential for associated growth; and available corporate announcements for keystone industry developments, new products and successes.

Structural insulation technology carries the potential to be game-changing within the industry. The technology is able to support increased energy efficiency, reduced amount of construction material (and therefore reduced cost), and in many cases easier installation, which itself helps to reduce construction labor costs associated with installation of conventional insulation systems. Thanks to increases in R&D and granted associated patents in recent years, new structural insulation technologies are expected to become commercially viable within the next five years. In this report, BCC Research analyzes each major viable structural insulation material and application, determines current market status, examines impact on future markets, and presents forecasts of growth over the next five years. Technological issues, including the latest trends, are assessed and discussed, as are the current and likely industry trends and updates. Sales of both new and replacement/retrofit structural insulation systems are considered.

BCC Research analyzes the structural insulation industry on a worldwide basis in terms of its manufacturing and the deployment of its technologies or products. BCC Research also examines key market drivers and headwinds and their roles in driving or throttling the global structural insulation market worldwide.

Report Includes:

- 68 data tables and 47 additional tables
- An overview of the global markets for advanced structural insulation
- Analyses of global market trends, with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Segmentation of the market by technology, end-users, application, and region
- Examination of the market dynamics and industry structure, specifically market drivers and opportunities in the global advanced structural insulation market
- Information on current and emerging end-users of advanced insulation, including commercial and residential buildings
- Relevant patent analysis
- Company profiles of major players in the market, including Knauf, Nova Chemicals, Owens Corning, Rockwool and Shelter Enterprises, Inc.

Get Request for Discount: https://www.trendsmarketresearch.com/report/discount/11645

Summary

In today’s market, residential and commercial builders are faced with myriad options for improving building energy efficiency including high-performance insulation, energy efficient equipment, and a growing cadre of smart systems and controls. When seeking green building certification or simply higher energy efficiency construction, cost effectiveness and multiple benefits become critical factors in selecting energy efficient, green technologies. Structural insulation includes a group of rapidly growing, multibenefit residential and commercial building technologies designed to greatly improve insulation capacity while also advancing building strength and providing several other important benefits, including reduced installation cost, exceptionally fast framing, reduced weight, disaster resistance, and reduced sound penetration.

Even with its strong benefits, structural insulation—including structural insulated panels (SIPs), insulated concrete forms (ICFs), insulated concrete blocks/concrete masonry units, and insulated concrete—global insulation markets carry much opportunity for growth, development and increased market penetration by structural insulation. The technologies face a building industry that is at once hungry for cost saving, time saving, and green building systems, but that also cautiously resists change. Some technologies, such as insulated concrete blocks/masonry units carry a strong advantage, in that they are nearly dropin replacements for existing building technologies. This greatly lowers risk and limits the need for extensive worker training and expertise. In contrast, SIPs and especially ICFs require skilled, experienced installers to ensure proper application. Many regions are approaching a critical mass of such skilled labor, but others lag behind, slowing market development. This study seeks to characterize these and other key market headwinds and drivers, identify technologies and applications that are leading structural insulation development and market penetration, and provide carefully benchmarked, reliable data on market valuations in the structural insulation industry through 2023.

Data on market splits within commercial buildings have been historically very difficult and costly to identify. This report, however, has a significant and unique benefit of providing detailed market breakdowns by a total of seven commercial building categories, including commercial office buildings, retail, education, healthcare, hotels and restaurants, institutional and assembly buildings, and warehouses and storage. Additionally, markets are also broken down by technology, including SIPs: polystyrene (EPS or XPS) insulation; SIPs: polyurethane or polyisocyanurate insulation; SIPs: other insulation material; ICFs: polystyrene (EPS or XPS) insulation; ICFs: other insulation; insulated concrete
blocks; and insulated concrete. Along with detailed splits by region and by key countries/major economies, the project provides deep insight to corporations and other market players seeking to make critical business decisions.

The following table and figure present market values for aggregated application categories. The structural insulated panels (SIPs) and insulated concrete forms (ICFs) market segment includes the following individual technologies: SIPs with polystyrene (expanded polystyrene [EPS] or extruded polystyrene [XPS]) insulation, SIPs with polyurethane or polyisocyanurate insulation, SIPs with other insulation, ICFs with polystyrene (EPS or XPS) insulation, and ICFs with other insulation. The insulated concrete and insulated concrete blocks category includes insulated concrete based on all relevant insulating materials, and insulated concrete blocks (i.e., insulated concrete masonry units [CMUs]).

Make an enquiry before Buying: https://www.trendsmarketresearch.com/checkout/11645/Single

Membrane Technology For Liquid And Gas Separations applications should grow from$5.1 billion by 2023

2020-01-28T09:45:15.991Z

The U.S. market for membrane modules used in liquid and gas separation applications should grow from $3.8 billion in 2018 to $5.1 billion by 2023 at a compound annual growth rate (CAGR) of 6.0% from 2018 to 2023.

Report Scope:

This report is primarily a study of the U.S. market, but due to the international presence of many industry participants, global activities are included where appropriate. Values are given in U.S. dollars, and revenue is counted at the manufacturer level. Forecasts are in constant U.S. dollars, and growth rates are compounded. Five-year projections are provided for market activity and values. Industry structure, technological trends, pricing considerations, R&D, government regulations, company profiles, and competitive technologies are included in the study. Only industrial-scale membrane products are evaluated, with no consumer products (i.e., point-of-use water systems) included in the analysis.

Request Report For Sample: https://www.trendsmarketresearch.com/report/sample/11644

Report Includes:

- 16 data tables and 30 additional tables
- Industry analysis of the U.S. market for membrane technology used in the liquid and gas chromatography
- Analyses of market trends with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Significant developments in the membrane technology market and quantification of various market sectors and outlining of the companies active in those areas
- Information on a range of filtration types and their applications in potable water, process water and wastewater treatment; food and beverage processing; biopharmaceuticals production; other large-scale liquid separations; and industrial gas separation etc.
- Coverage of leading liquid-gas chromatography technologies, including reverse osmosis, nanofiltration, ultrafiltration, microfiltration, electrochemical processes, gas separation and pervaporation
- Evaluation of the growth inhibiting drivers and current trends, with statistical information on markets, applications, industry structure and dynamics, along with technological developments
- Detailed company profiles of major players in the industry, including 3M Purification, Alfa Laval, Evonik Industries AG, Honeywell UOP, MilliporeSigma, Toray Industries and W.L. Gore & Associates

Summary

The combined U.S. market for membranes used in liquid and gas separation applications was worth approximately REDACTED in 2017 and is forecast to grow at a compound annual growth rate (CAGR) of REDACTED during the five-year period from 2018 through 2023.

Get Request for Discount: https://www.trendsmarketresearch.com/report/discount/11644

Membranes are essential to a range of applications from potable water, process water and wastewater treatment to power generation, pharmaceuticals production, food and beverage processing, and separations needed for manufacturing chemicals, electronics, fuels, and a range of other products. Primary drivers for membrane sales include consumer demand for high-quality products, increased regulatory pressure, deteriorating natural resources, and the need for environmental and economic sustainability.

The United States consumes between REDACTED to REDACTED of all membrane modules produced worldwide,depending on application. In 2017, conventional liquid separation methods, includingreverse osmosis (RO), nanofiltration (NF), ultrafiltration (UF), microfiltration (MF), electrochemicalprocesses such aselectrodialysis (ED), and a few other applications, accounted for about REDACTED of U.S. demand, or about REDACTED. Gas separation methods and pervaporation comprised the remaining REDACTED, or REDACTED. Membrane module sales for liquid separations are forecast to increase at a CAGR of REDACTED while combined sales of products used in gas separation, pervaporation and novel
processes are predicted to grow at a CAGR of REDACTED through the forecast period.

By technology type, the market for RO owes its high growth rate to the expanding market for desalination, increased applications in process water treatment and interest in reclaiming used water. NF membrane products are being used in applications beyond their traditional role in water treatment to meet demanding refinery, chemical and pharmaceutical separations involving solvents.

MF and UF products are in demand for treating potable and process water, but the most rapid growth in this sector is in wastewater treatment with membrane bioreactors and the manufacture of biological drugs. The food and beverage industries are also long-time, steady purchasers of membranes, with these pore sizes used in the concentration, clarification and microbial stabilization processes.

Largely replaced by other membrane technologies for drinking water treatment, ion exchange membranes used in electrochemical processes are finding important niche markets in the food and fine chemicals industries and the production of hydrogen by water splitting. Configured as membrane adsorbers, ion exchange membranes also have growing applications for separations required for biopharmaceutical production.

Several new membrane products for gas separation are on the cusp of commercialization. After years in which there was a lack of suitable materials for large and promising applications in several areas, inorganic and organic/inorganic hybrid membranes are poised to enter the market for uses such as hydrogen separation and natural gas purification. Pervaporation is also on the verge of widespread adoption for several lucrative uses in fuel manufacturing and refinery processes.

Make an enquiry before Buying: https://www.trendsmarketresearch.com/checkout/11644/Single

2018 Manufacturing Research Review

2020-01-28T09:44:48.613Z

The global market for cranes will grow from nearly $29.4 billion in 2017 to $35.9 billion by 2022 with a compound annual growth rate (CAGR) of 4.1% for the period of 2017-2022.
The global market for meat processing equipment should grow from $10.7 billion in 2017 to $15.3 billion by 2022 with a compound annual growth rate (CAGR) of 7.4% for the period of 2017-2022.
The global market for industrial boilers should increase from $13.0 billion in 2018 to $18.2 billion in 2023 at a compound annual growth rate (CAGR) of 6.9% for 2018-2023. Request Report For Sample: https://www.trendsmarketresearch.com/report/sample/11643

Summary

Over the past few years, the manufacturing industry continued to remain a critical force in both advanced and developing economies. The sector has gone through significant transformations bringing out new opportunities and challenges to business leaders and policy makers.

Get Request for Discount: https://www.trendsmarketresearch.com/report/discount/11643

In advanced economies, the manufacturing sector has largely concentrated on promoting innovation, productivity and trade more than growth and employment. In many advanced economies manufacturing sector has to consume more services and rely heavily on them to operate. The focus on innovation has led companies to explore new opportunities.

In recent years, manufacturers have adopted emerging technologies such as machine learning, internet of things (IoT), augmented reality, virtual reality and others which have provided them with numerous opportunities and transformed their operations and increased efficiencies. Manufacturers have been aggressively pursuing this digital transformation to compete and gain a foothold in the marketplace.

This 2018 Manufacturing Research Review provides a sampling of the type of quantitative market information, analysis and guidance that has been aiding business decision making since BCC Research was founded in 1971. It includes highlights of reports published in 2018 on the following manufacturing markets:

MFG032C Cranes: Technologies and Global Markets.
MFG043A Smart Robotics in Manufacturing: Global Markets to 2022.
MFG042A Industry 4.0 Technologies: Global Market Through 2023.
MFG033C Industrial Boilers: Technologies and Developing Markets.
MFG065A Meat and Poultry Processing Equipment: Global Markets Through 2022.
MFG040A North American E-cigarette and Legal Cannabis Markets.

Make an enquiry before Buying: https://www.trendsmarketresearch.com/checkout/11643/Single

Information Technology growth rate (CAGR) of 14.9% for the period of 2017-2022.

2020-01-28T09:44:27.591Z

The global market for cloud and data center networks will grow from $17.0 billion in 2017 to $34.0 billion by 2022, with a compound annual growth rate (CAGR) of 14.9% for the period of 2017-2022.
The global market for software-defined storage products and services reached $8.5 billion in 2017. The market should reach $18.2 billion by 2022, growing at a compound annual growth rate (CAGR) of 16.4% during 2017-2022.
The global market for internet of things in retail should grow from $21.7 billion million in 2018 to reach nearly $50.0 billion by 2023 at a compound annual growth rate (CAGR) of 18.0% for the period of 2018-2023. Request Report For Sample: https://www.trendsmarketresearch.com/report/sample/11642

Summary

Internet of Things (IoT) and cloud computing is one of the key technology trends to emerge in recent years. With IoT technologies helped connecting technical devices and other smart objects to the internet and to each other, cloud computing has provided users with cost-effective, efficient and more secure alternatives to transform and enhance the businesses. These advanced technologies in an attempt to resolve several economic and social issues, are helping in creating a perfect connection between the physical and digital worlds.

Get Request for Discount: https://www.trendsmarketresearch.com/report/discount/11642

IoT has turned the concept of smart-homes and devices, and workplaces into a reality. The technology is laying foundation for enhancing operations in various industries such as in retail and manufacturing industries. With the latest developments in the field of IoT, and cloud and datacenters, industries are capable of revamping the entire business processes, from product design to system delivery to selling at point of sales (POS).

While these trends are already transforming businesses, the concept of artificial intelligence (AI) is still on the horizon. This level of processing will increase the requirements on network performance as well as storage of organizations’ intellectual or business data. Thus, the benefits of cloud and data center networks are starting to justify new investments, as legacy networks and storage technologies lack in capacity to deal wih today’s dynamic application environment.

The Information Technology Research Review provides a brief of the type of quantitative market information, analysis and guidance that has been aiding business decision making since BCC Research was founded in 1971. It includes highlights of several market research reports that were published in 2018 and are an efficient way for market professionals to keep up with the general market developments.

Below given are the list of topics that are covered in this research review.

IFT103A Cloud and Data Center Network Technologies: Global Market Through 2022.
IFT116A Software-defined Storage: Global Markets to 2022.
IFT135A The Internet of Things (IoT) in Global Retail Markets Through 2023.
IFT145A Internet of Things (IoT) Technologies for Process Manufacturing: Global Markets.
IFT149A Quantum Computing: Technologies and Global Markets to 2022.
IFT151A Smart Home Technologies: Global Markets to 2022.
IFT157A Global Markets and Technologies for Edge Computing Through 2023.

Make an enquiry before Buying: https://www.trendsmarketresearch.com/checkout/11642/Single

Mobile Wallet And Payment Technologies should grow from $138.5 billion by 2023

2020-01-28T09:44:07.060Z

The global market for mobile wallet and payment technologies should grow from $35.7 billion in 2018 to $138.5 billion by 2023 at a compound annual growth rate (CAGR) of 31.1% for the period of 2018-2023.

Report Scope:

The scope of this study includes market information on mobile wallet and payment technologies and their key segments, including applications, modes of payment, stakeholders and regions. However, the scope of the mobile wallet market excludes online payments methods such as IMPS, NEFT and RTGS that are followed in banks; payments through debit or credit cards (electronic fund transfers at the point of sales); and online trading. The mobile wallet includes only payments made through exclusive service providers using a personalized mobile wallet account.

By application, the mobile wallet and payment technology market is segmented into mobile commerce (mobile shopping, mobile bill payments, hospitality, and mobile entertainment and event pay), mobile ticketing (such as tickets and boarding passes for trains, buses, other metro transit options and airplanes), mobile coupon, mobile transfer, mobile micropayment and others.

Request Report For Sample: https://www.trendsmarketresearch.com/report/sample/11641

The market by mode of payment includes remote payment, which includes SMS and unstructured supplementary service data, and near-field communication (NFC), which includes NFC handsets, NFC chips and tags, NFC readers, NFC micro SD and NFC SIM/universal integrated circuit [UICC] cards.

In addition, the mobile wallet and payment technology market is segmented by stakeholders, including mobile network operators, handset and other hardware solution manufacturers, mobile payment networks and banks, operational support system (OSS) and business support system (BSS) solution providers, software developers and cloud computing, content and application aggregators, trusted service managers and other stakeholders.

The market breakdown by geographic region includes North America (U.S., Canada and Mexico); Europe, the Middle East and Africa (EMEA) (Germany, France, U.K., Italy and others), Asia-Pacific (China, India, Japan, Australia and others) and Rest of World (Argentina, Brazil and others).

The study undertakes an in-depth analysis of various market segments, and their revenue forecasts are given for all of the above-mentioned segments in the mobile wallet and payment technology market with estimated values derived from vendors’ total revenue. Market estimates are provided for 2017 and 2018 and forecast for 2023.

The report also includes a discussion of the major players across each regional market. Further, it explains the major drivers, restraints and challenges, and technologies of the market. The report concludes with a special focus on patents and the vendor landscape, which includes detailed profiles of major vendors in the global mobile wallet and payment technology market. Some of the companies profiled in the report include Alphabet Inc., PayPal Holding Inc., Paytm Mobile Solutions Pvt. Ltd, Visa Inc., Apple Inc., Google, Mastercard, Alibaba Group and Samsung electronics. Co. Ltd.

Report Includes:

- 83 data tables
- An overview of the global markets for mobile wallet and payment technologies
- Analyses of global market trends, with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Information on key segments of mobile wallet and payment technologies including application, mode of payment, and region
- Description of components of mobile payment and infrastructure status for NFC (near-field communication)
- Snapshot of mobile wallet procurement systems and life cycle management
- Insights of legislation and regulations related to industry
- Profiles of major companies of the industry including, American Express, Citigroup Inc., Fidelity National Information Services Inc., Mastercard and Visa Inc.

Get Request for Discount: https://www.trendsmarketresearch.com/report/discount/11641

Summary

Mobile payments are transactions through an individual’s bank account, debit card or credit card. However, mobile wallet payments are processed through a mobile wallet account. The key objective of the mobile wallet is to provide a user with an electronic wallet where all the contents of a real wallet, such as cash and cards, are electronically available at anytime and anywhere.

The global mobile wallet and payment technology market was valued at $27.9 billion in 2017 and is estimated to grow at a compound annual growth rate (CAGR) of 31.1% to reach $138.4 billion by 2023 due to rapid growth of the e-commerce industry, the growing impact of social media and the increasing penetration of smartphones.

The rapid extension of the e-commerce industry is one of the major factors driving market growth. In recent years, more than half of the world’s internet traffic has come from mobile devices such as smartphones, tablets and PCs. The major reason for rising demand and growth of the e-commerce industry is the convenience offered by mobile wallet and payment gateways. However, slower adoption of contactless payments, fraud and risk of breach are expected to hinder the growth of this market.

Make an enquiry before Buying: https://www.trendsmarketresearch.com/checkout/11641/Single

Global market for blood screening and typing should grow from $9.9 billion by 2023

2020-01-28T09:43:39.584Z

The global market for blood screening and typing should grow from $7.7 billion in 2018 to reach $9.9 billion by 2023 at a compound annual growth rate (CAGR) of 5.0% for the period of 2018-2023.

Report Scope:

This report focuses on the screening and analysis of donor blood and patient blood. It covers the current market dynamics and various forces that are impacting the market. Two markets are analyzed: blood screening and blood typing. By technology, the blood screening market is segmented into serological technologies Enzyme linked immunosorbent assay (ELISA) and chemiluminescence immunoassay (CLIA), agglutination tests such as gel card agglutination, microplate-based agglutination, and lateral flow tests), nucleic acid amplification technologies (PCR-based and non-PCR based), microbiology techniques (blood culture and antimicrobial susceptibility tests) and niche technologies such as microarray, DNA sequencing.

Request Report For Sample: https://www.trendsmarketresearch.com/report/sample/11640

By blood supply, the market is segmented into patient blood and donor blood. Patient blood supply analysis covers the qualitative detection of infectious diseases such as sexually transmitted diseases and blood-borne infections like sepsis, and blood grouping and typing analysis tests. Donor blood testing involves analysis of donor blood units, including infectious disease screening and blood grouping tests.

By end-user the market is segmented into hospitals, standalone blood banks and reference laboratories. By region, the blood screening and typing market is segmented into North America, Europe, the Asia-Pacific region and Rest of the World (ROW). ROW includes South America, the Middle East and Africa. This report also covers the competitive landscape, detailing the companies engaged in offering products for blood screening and typing. Detailed profiles of the top leading companies are also included.

Report Includes:

- 31 data tables and 34 additional tables
- An overview of recent key developments in the global blood screening and typing market and a look ahead at the next five years
- Analyses of global market trends with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Quantitative data covering the overall market by analyzers, kits, reagents and consumables, immunoassay techniques, technology types, microbiology techniques, blood types and consumer groups
- Regional dynamics of the blood screening market covering North America, Europe, Asia-Pacific and Rest of the world including countries of South America, Middle East and Africa
- Study of impact analysis and discussion of technological, regulatory, and economic trends that are affecting the global blood screening market
- Company profiles of the leading market players, including Abbott Laboratories, Becton, Dickinson and Co., Bio-Rad Laboratories, Danaher Corp. and Thermo Fisher Scientific, Inc.

Get Request for Discount: https://www.trendsmarketresearch.com/report/discount/11640

Summary

The global blood screening and typing market was valued at REDACTED in 2017 and is expected to witness a compound annual growth rate (CAGR) of REDACTED to reach a value of REDACTED by 2023. Growth is primarily driven by the increasing prevalence of chronic and infectious disease like sexually transmitted disease and blood infections. Increases in automation have had a profound impact on the analysis of large sample units of blood with limited errors. New technological products like sequencing and microarrays are expected to propel the growth of the market.

This report focuses on the screening and analysis of donor blood and patient blood. It covers the current market dynamics and various forces that are impacting the market. Two markets are analyzed: blood screening and blood typing. By technology, the blood screening market is segmented into serological technologies Enzyme linked immunosorbent assay (ELISA) and chemiluminescence immunoassay (CLIA), agglutination tests such as gel card agglutination, microplate-based agglutination, and lateral flow tests), nucleic acid amplification technologies (PCR-based and non-PCR based), microbiology techniques (blood culture and antimicrobial susceptibility tests) and niche technologies such as microarray, DNA sequencing.

By blood supply, the market is segmented into patient blood and donor blood. Patient blood supply analysis covers the qualitative detection of infectious diseases such as sexually transmitted diseases and blood-borne infections like sepsis, and blood grouping and typing analysis tests. Donor blood testing involves analysis of donor blood units, including infectious disease screening and blood grouping tests.

By end-user the market is segmented into hospitals, standalone blood banks and reference laboratories. By region, the blood screening and typing market is segmented into North America, Europe, the Asia-Pacific region and Rest of the World (ROW). ROW includes South America, the Middle East and Africa. This report also covers the competitive landscape, detailing the companies engaged in offering products for blood screening and typing. Detailed profiles of the top leading companies are also included.

Make an enquiry before Buying: https://www.trendsmarketresearch.com/checkout/11640/Single

Global market for needle-free devices should grow from $4.6 billion by 2023,

2020-01-28T09:43:18.606Z

Report Highlights

The global market for needle-free devices should grow from $3.0 billion in 2018 to $4.6 billion by 2023, increasing at a compound annual growth rate (CAGR) of 9.3% from 2018 to 2023.

Report Scope:

This report provides a detailed description of needle-free devices and the latest technologies in the market. The report includes market estimates for different types of needle-free devices. The report also includes recent technological developments and assessments of product performance in the market.

Based on the product type, the global needle-free device market is segmented into Needle-free Injectors, Inhaler technologies, Transdermal patch technologies and Other novel technologies (e.g., microneedles and pen needles).

Request Report For Sample: https://www.trendsmarketresearch.com/report/sample/11639

Based on the application, the global needle-free device market is segmented into Pain management, Vaccine delivery, Insulin delivery and Pediatric drug delivery.

The report includes a list of marketed and pipeline products available in the market. The report discusses the qualitative and quantitative factors influencing market growth. The market drivers, restraints and opportunities are discussed in the report.

This report discusses some of the major drivers and restraints in the global needle-free device market, as well as the competition in the global needle-free device market and the key players' strategies and performances. The discussion is focused on the major market players, trends in product launches, collaborations, and mergers and acquisitions. The report also emphasizes on the company profiles of major vendors including company overview, key product offerings, financial statistics, and other developments. The report also provides insights on the market share and upcoming regional demand for the needle-less technologies.

Some of the major market players discussed in the report are 3M, Antares Pharma AG, Medtronic, Novartis and Teva Pharmaceuticals. For market estimates, data has been provided for the year 2017 as the base year, with forecasts for 2018 through 2023. Estimated values used are based on manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Report Includes:

- 36 data tables and 34 additional tables
- Detailed overview of the global markets for needle-free devices and technologies within the industry
- Analyses of global market trends with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Country specific data and analysis for United States, Canada, Mexico, France, Germany, U.K., Spain, China, India, Japan, South Korea, Middle East and Africa
- Assessment of the recent developments, key technological updates and product performance within the needle-free devices market
- Insight into various needle-free technologies that are used in drug delivery and their various application areas
- A look at the government regulations that can affect the global needle-free devices market
- Identification of the competitive landscape of the market with the leading market players, suppliers and pharmaceutical partners
- Profiles of major vendor companies, including 3M, AstraZeneca PLC, Bristol-Myers Squibb, GlaxoSmithKline PLC (GSK), Medtronic, Merck Serono S.A., and Teva Pharmaceutical Industries Ltd.

Get Request for Discount: https://www.trendsmarketresearch.com/report/discount/11639

Summary

The global market for needle-free technologies was worth REDACTED in 2017. The market is expected to increase at a compound annual growth rate (CAGR) of REDACTED during the forecast period 2018-2023. Growth in this segment is being fueled by evolving market dynamics and a growing interest in safe, effective and advanced needle-free drug delivery technologies.

There are several needle-free technologies such as needle-free injectors, transdermal patches and other novel technologies currently available in the market. In terms of technological development, there is an exciting product pipeline for extensive research and development. Healthcare providers seek devices and technologies that improve patient compliance and ease in drug administration. Hence, needle-free devices are expected to have a significant scope of growth, with numerous driving factors discussed in this report.

Major drivers of the global needle-free device market are as follows -
- Increasing incidence of needlestick injuries.
- Growing cases of needle phobia.
- Increasing demand for painless drug delivery.
- Product innovations.
- Increased prevalence of diabetes globally.
- Increasing incidence of blood-borne diseases globally.
- Public awareness of HIV/AIDS and the significance of needle-free devices in preventing HIV.

At the same time, novel drug delivery technologies help retain market leadership, protect sales revenues and bring competitive value to pharmaceutical companies and technology partners. Transdermal technologies have created new opportunities for pharmaceutical companies seeking to create delivery mechanisms for existing molecules with no viable delivery system and existing drugs that could benefit from additional delivery systems, such as compounds that were previously unable to be delivered through the skin. However, market growth is hindered by certain market restraints.

Make an enquiry before Buying: https://www.trendsmarketresearch.com/checkout/11639/Single.

Global market for cancer profiling technologies should grow from $45.2 billion in 2018 to $90.6 billion by 2023

2020-01-28T09:42:54.585Z

The global market for cancer profiling technologies should grow from $45.2 billion in 2018 to $90.6 billion by 2023 with a compound annual growth rate (CAGR) of 14.9% for the period of 2018-2023.

Report Scope:

Cancer biomarkers have gained significant importance in the drug-development process, and the market is an emerging segment. To gain an understanding of the market dynamics, market size and competitive landscape, a detailed analysis of cancer biomarker market and cancer profiling technologies and new developments is needed. Microarray technologies provide analysis of tens of thousands of molecules for a variety of assays, including drug binding, molecular interactions, enzyme activity and pathway identification. These microarrays, which include DNA microarrays, protein microarrays, tissue microarrays, low complexity microarrays and carbohydrate microarrays, are excellent tools for gene expression profiling, biomarker profiling and diagnostics.

Request Report For Sample: https://www.trendsmarketresearch.com/report/sample/11638

Pharmaceutical and biotechnology researchers use microarrays to streamline drug target identification, selection, validation and predictive testing. Rapid growth in the clinical research and diagnostic devices markets holds great potential for applications of microarray technology, including basic research, clinical trials and diagnostic devices. This report examines various microarray platforms and the technologies that are utilized to detect DNA and proteins for the purpose of drug discovery, disease diagnosis and disease monitoring. This report also examines companies that are actively developing and marketing microarray instrumentation or microarray biochips.

The report categorizes the biomarkers and profiling market and provides market data, market drivers, trends and opportunities, top-selling products, key players and competitive outlook. This report will also provide market tables and also provides company profiles.

This report analyzes the cancer profiling and pathways market: technologies market, tools market, and application market (diagnosis, drug development and discovery). This report also examines recent studies, microRNA detection and profiling, clinically oriented microRNA profiling in several human cancers. The report covers epigenetic, methylation and miRNA products in development, products in clinical trials, currently marketed and clinical-stage development products. Relationship between miRNAs and epigenetics is also examined. This report categorizes the market for epigenetics, forecasting the market value in revenue by analyzing the current and future trends in research, diagnostics and therapeutics industries. This report also looks at SNPs analysis instruments, reagents, software and services, providing information critical to understanding the business behind this new technology.

The following technologies and segments are excluded from this report: detailed instruments, pharmacogenomics, combinatorial chemistry, biochip, bioinformatics and high-throughput screening (HTS). Uses of emerging technologies in drug discovery such as lab-on-a-chip (LOAC), nanotechnology, and RNA interference (RNAi) also are not discussed here.

Report Includes:

- 91 tables
- An overview of the global market for cancer profiling and pathways
- Analyses of global market trends, with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Discussion of products in this market, newly emerging tools, diagnostics and therapeutics, and their impacts on the market
- Examination of evolving methods, such as microarray analysis, multiplex PCR, and quantitative real-time PCR, which are integral to deciphering molecular mechanisms involved in gene function, biological development, and disease progression, and are important tools in the discovery and development of new drug targets and diagnostic biomarkers
- Identification of important cancer profiling techniques, market shares by types of products on the market, and market shares by company, as well as types of cancers and biomarkers
- Coverage of epigenetic, methylation, and miRNA products in development, products in clinical trials and currently marketed, and clinical-stage development products
- Company profiles of key players in the market

Get Request for Discount: https://www.trendsmarketresearch.com/report/discount/11638

Summary

The global healthcare industry is undergoing key developments, advanced point-of-care diagnostics, availability of cost-effective treatment modalities and personalized medicine, which not only offers efficient early stage diagnosis, while also treating cancer conditions in order to reduce the overall healthcare cost and disease burden. This is one technology which has the potential to revolutionize cancer therapeutics and diagnostics in the healthcare sector.

An effective management and administration of targeted therapeutics and monitoring of cancer condition requires frequent profiling of patient’s tumor mutations. Currently, the profiling of cancer has become very critical for cancer diagnosis, clinical trials, research and drug development efforts. With the launch of novel and efficacious targeted therapies that are developed and approved, profiling of tumors will become essential for therapy, patient selection and monitoring.

It is critical to understand the multivariate nature of cancer is and drug response also depends on molecular profiling at genetic, epigenetic and protein levels. Biomarkers, as defined by the National Institutes of Health (NIH), are “characteristics that are objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention.” A biomarker has to be reliable, measurable, specific and predicative.

Cancer is a highly heterogenous disease involving dysregulation of multiple pathways regulating many fundamental cell processes such as growth, death, proliferation, differentiation and migration. Minor differences and subtle feedback nuances such as tumor microenvironments and endocrine feedback loops, often translate into major differences between cancers, and between patients who have the same cancers. These activities of molecular networks that orchestrate metabolic or cytoskeletal processes, or harmonize these by signal transduction, are altered in a complex manner by many genetic mutations in concert with the environmental context. The challenge is to understand these multivariate
dysregulations, with respect to both to how it arises from diverse genetic mutations and to how it can be treated. High-throughput experimental platform technologies ranging from genomic sequencing to transcriptomic, proteomic and metabolomic profiling are now commonly used for molecular-level characterization of tumor cells and surrounding tissues.

The major causes of cancer are infection and chronic inflammation. In this report, a general overview of the connection between cancer profiling technologies and cancer is provided. A better insight of these connections can yield novel diagnostic, preventive, and therapeutic strategies to reduce the global cancer burden. Gene expression profiling methods enable the detection and measurement of multiple expressed gene transcripts in a single RNA sample. Newer and improved methods for microarray analysis, multiplex PCR and quantitative real-time PCR are integral to deciphering the molecular mechanisms involved in gene function, cancer development and disease progression, and are important
tools in the discovery and development of new drug targets and diagnostic biomarkers. Innovative tools and techniques for sequencing and tumor profiling are growing and may represent excellent opportunities for life science suppliers.

Make an enquiry before Buying: https://www.trendsmarketresearch.com/checkout/11638/Single